| Product Code: ETC9977332 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant increase in subcutaneous drug delivery devices import shipments in 2024, with top exporting countries including Mexico, Taiwan, China, Italy, and Switzerland. The market remained relatively competitive with low concentration, indicating a diverse range of suppliers. The impressive compound annual growth rate (CAGR) of 11.55% from 2020 to 2024, coupled with a growth rate of 12.87% from 2023 to 2024, highlights a robust demand for subcutaneous drug delivery devices in the US market. This trend suggests a positive outlook for the industry in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Subcutaneous Drug Delivery Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Subcutaneous Drug Delivery Devices Market - Industry Life Cycle |
3.4 United States (US) Subcutaneous Drug Delivery Devices Market - Porter's Five Forces |
3.5 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Subcutaneous Drug Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term drug delivery |
4.2.2 Growing demand for minimally invasive drug delivery methods |
4.2.3 Technological advancements in subcutaneous drug delivery devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of subcutaneous drug delivery devices |
4.3.2 High cost associated with development and manufacturing of advanced drug delivery devices |
5 United States (US) Subcutaneous Drug Delivery Devices Market Trends |
6 United States (US) Subcutaneous Drug Delivery Devices Market, By Types |
6.1 United States (US) Subcutaneous Drug Delivery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.4 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Pen injectors, 2021- 2031F |
6.1.5 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Auto-injectors, 2021- 2031F |
6.1.6 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Wearable injectors, 2021- 2031F |
6.1.7 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Needle-free injectors, 2021- 2031F |
6.2 United States (US) Subcutaneous Drug Delivery Devices Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.2.3 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.2.4 United States (US) Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 United States (US) Subcutaneous Drug Delivery Devices Market Import-Export Trade Statistics |
7.1 United States (US) Subcutaneous Drug Delivery Devices Market Export to Major Countries |
7.2 United States (US) Subcutaneous Drug Delivery Devices Market Imports from Major Countries |
8 United States (US) Subcutaneous Drug Delivery Devices Market Key Performance Indicators |
8.1 Adoption rate of subcutaneous drug delivery devices by healthcare providers |
8.2 Number of new product launches in the subcutaneous drug delivery devices market |
8.3 Patient satisfaction and acceptance of subcutaneous drug delivery devices |
9 United States (US) Subcutaneous Drug Delivery Devices Market - Opportunity Assessment |
9.1 United States (US) Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Subcutaneous Drug Delivery Devices Market - Competitive Landscape |
10.1 United States (US) Subcutaneous Drug Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Subcutaneous Drug Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |